ClinicalTrials.govpublic full text
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
gastric cancer, japanese, phi, safety and tolerability, cediranib in combination with cisplatin plus a fluoropyrimidine, cediranib, capecitabine, s-1, cisplatin, untreated locally advanced or metastatic unresectable gastric cancer (gc), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856270
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.